Risk Model for Predicting Survival Outcomes Using Functional Exercise and Patient‐Reported Outcomes in Fibrotic Interstitial Lung Disease: A Prospective Observational Study
Respirology · 2025
DOI: 10.1111/resp.70076 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Respirology, 2025. Verfasst von Lan-Yan Yang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Clinical Trial, Department of Medical Research, Taichung Veterans General Hospital, Taichung, Taiwan. Hauptthemen laut MEDLINE: Patient Reported Outcome Measures, Lung Diseases, Interstitial, Exercise. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Science and Technology Council, Taichung Veterans General Hospital.
Abstract (Originalsprache)
Background and Objective Fibrotic interstitial lung disease (F‐ILD) has high mortality, necessitating multidimensional staging to assess severity, predict prognosis, and guide treatment. However, the gender‐age‐physiology (GAP) index lacks patient‐reported outcome measures (PROMs) and exercise test parameters, and traditional methods may miss complex variable interactions. The study aimed to develop a risk model of mortality in F‐ILD using routine PROMs and exercise test parameters, and to compare the predictive performance with GAP staging system.
Methods
Between December 2018 and December 2022, 246 patients from the ILD Prospective Registry with at least 1 year of follow‐up (excluding death) were enrolled. Baseline assessments included GAP, 1MSTS, 6MWD, mMRC, SGRQ, and SF36. A tree‐based risk model was developed and validated with a 2:1 split. Kaplan–Meier curves and Cox regression were used to estimate survival and hazard ratios, with statistical significance set at p < 0.05.
Results
The very‐high‐risk group (SGRQ > 34.5, 1MSTS < 21) had a significantly higher hazard ratio (HR = 5.13; 95% CI: 2.54–10.35) compared to the non‐very‐high‐risk group. Their 1‐, 2‐, and 5‐year mortality rates were 28.87%, 47.18%, and 82.42%, respectively, similar to GAP stage III but with narrower confidence intervals.
Conclusion
This study developed a prognostic model for F‐ILD combining PROMs and functional exercise data. The model, which includes the SGRQ, 6MWD, and 1MSTS, outperforms GAP staging, offering benefits like reduced patient fatigue and improved monitoring. Multicenter studies are needed to validate these findings. Trial Registration The study was registered on ClinicalTrials.gov (NCT06476470) image
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Clinical Trial, Department of Medical Research, Taichung Veterans General Hospital, Taichung, Taiwan.
- Integrated Care Center of Interstitial Lung Disease, Taichung Veterans General Hospital, Taichung, Taiwan.
ORCID-Profile: Pin-Kuei Fu
Förderung
- National Science and Technology Council
- Taichung Veterans General Hospital
Zitieren
APA
Yang, L. Y., Yang, H. T., Yu, Y. H., & Fu, P. K. (2025). Risk Model for Predicting Survival Outcomes Using Functional Exercise and Patient‐Reported Outcomes in Fibrotic Interstitial Lung Disease: A Prospective Observational Study. Respirology. https://doi.org/10.1111/resp.70076
Vancouver
Yang LY, Yang HT, Yu YH, Fu PK. Risk Model for Predicting Survival Outcomes Using Functional Exercise and Patient‐Reported Outcomes in Fibrotic Interstitial Lung Disease: A Prospective Observational Study. Respirology. 2025. doi:10.1111/resp.70076
BibTeX
@article{Yang2025,
author = {Yang, Lan-Yan and Yang, Hsin-Ting and Yu, Yi-Hsuan and Fu, Pin-Kuei},
title = {Risk Model for Predicting Survival Outcomes Using Functional Exercise and Patient‐Reported Outcomes in Fibrotic Interstitial Lung Disease: A Prospective Observational Study},
journal = {Respirology},
year = {2025},
doi = {10.1111/resp.70076}
}
EUVIMED